Earlier Thursday, Galectin
Therapeutics (GALT) announced that Dr.
Baseline data was collected from patients screened for the NASH-CX Phase 2 clinical trial sponsored by Galectin
Discovery and characterization of an epithelial-specific galectin
in the endometrium that forms crystals in the trophectoderm.
Reagents for galectin
3- and high-sensitivity troponin I were generously provided for free by Abbott, Wiesbaden, Germany.
Fibrotic liver disease company Galectin
Therapeutics (NasdaqCM:GALT) reported on Tuesday the receipt of a Notice of Allowance from the Australian Government Patent Office for its patent application for "Composition of Novel Carbohydrate Drug for Treatment of Human Diseases.
-3 is the only chimera galectin
in vertebrates, and it has been widely studied.
Product Pipeline Review - 2014', provides an overview of the Galectin
Therapeutics is currently conducting a Phase 1 clinical trial to evaluate the safety, tolerability and exploratory biomarkers for efficacy for single and multiple doses of GR-MD-02 over four weekly doses of GR-MD-02 treatment in patients with fatty liver disease with advanced fibrosis.
In addition, excessive amounts of the most studied galectin
-3, makes cancer more aggressive.
3 aggravates joint inflammation and destruction in antigen-induced arthritis.
27 March 2012 -- US drug developer Galectin
Therapeutics Inc (NASDAQ:GALT) said on Monday it had generated aggregate gross proceeds of USD12m (EUR9m) from its public offering of units including the full use by the underwriter of the over-allotment option.
Background and Design: In view of the evolving knowledge about the presence of the potent proinflammatory galectin
-3, a member of the galectin
family, in the cells (mainly T-lymphocytes) playing a key role in the inflammation process.